SUNLIGHT illuminates the activity of bevacizumab
- PMID: 37198414
- DOI: 10.1038/s41571-023-00784-9
SUNLIGHT illuminates the activity of bevacizumab
Comment on
-
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.N Engl J Med. 2023 May 4;388(18):1657-1667. doi: 10.1056/NEJMoa2214963. N Engl J Med. 2023. PMID: 37133585 Clinical Trial.
References
Original article
-
- Prager, G. W. et al. Trifluridine–tipiracil and bevacizumab in refractory metastatic colorectal cancer. N. Engl. J. Med. 388, 1657–1667 (2022) - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources